论文部分内容阅读
我院自1990年至1999年对102例不稳定性心绞痛(UAP)患者,分别采用小剂量尿激酶联合肝素治疗与冠心病常规治疗,两者进行比较,旨在探索溶栓联合抗凝疗法对UAP的治疗价值。 102例UAP患者,男78例,女24例;年龄(55±5)岁;病程1个月至1年。分为两组,小剂量尿激酶+肝素治疗组67例,男59例,女8例;常规治疗对照组35例,男31例,女4例。全部病例符合1997年WHO冠心病心绞痛诊断与分型标准,并经心电图、心肌酶检查除外AMI。
Our hospital from 1990 to 1999, 102 cases of unstable angina (UAP) patients were treated with low-dose urokinase heparin and conventional treatment of coronary heart disease, the two were compared to explore the thrombolytic therapy combined with anticoagulation UAP treatment value. 102 patients with UAP, 78 males and 24 females; aged (55 ± 5) years; duration of 1 month to 1 year. Divided into two groups, low-dose urokinase + heparin group of 67 patients, 59 males and 8 females; conventional treatment control group of 35 patients, 31 males and 4 females. All cases were in line with the 1997 WHO diagnosis and classification of coronary heart disease angina pectoris, and ECG, myocardial enzyme test except AMI.